Intensive Scheduled Management strategy for improving blood pressure control in patients in primary care

ISRCTN ISRCTN05874865
DOI https://doi.org/10.1186/ISRCTN05874865
Secondary identifying numbers NA 4884
Submission date
14/08/2003
Registration date
08/09/2003
Last edited
19/10/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Marshall Godwin
Scientific

Centre for Studies in Primary Care
220 Bagot Street
Kingston, Ontario
K7L 5E9
Canada

Phone +1 613-549-4480
Email godwinm@post.queensu.ca

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeQuality of life
Scientific title
Study acronymISM
Study objectivesComparing intensive scheduled management of hypertension (aggressive achievement of target blood pressure over 16 weeks) with usual management of hypertension.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedHypertension
InterventionThis study is designed to test the premise that guidelines, to be effective in primary care, need to be operationalised for the practitioner. To this end we have devised a protocol where medications are initiated at the recommended starting dose and increased by one recommended increment before adding the next drug. The goal is to increase the medications over the 16-week period such that, if necessary to reach the target blood pressure level, a patient is on a medium dose of three different antihypertensive agents.
Intervention typeOther
Primary outcome measureBlood pressure control on 24-hour Ambulatory Blood Pressure Monitoring (ABPM), measured at 16 weeks and one year.
Secondary outcome measures1. Patient quality of life
2. Physician compliance with the intensive protocol
3. Patient compliance with medication
4. Adverse effects
Overall study start date01/07/2002
Completion date01/11/2006

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteria1. Adults (age 18 and older) who are patients of family physicians
2. Must be diagnosed with essential hypertension but not have yet achieved target levels
Key exclusion criteria1. A diagnosis of secondary hypertension
2. Pregnancy
3. Hypertension management primarily by a consultant
4. Inability to provide informed consent
Date of first enrolment01/07/2002
Date of final enrolment01/11/2006

Locations

Countries of recruitment

  • Canada

Study participating centre

Centre for Studies in Primary Care
Kingston, Ontario
K7L 5E9
Canada

Sponsor information

The Heart and Stroke Foundation of Ontario (Canada)
Charity

1920 Yonge Street
4th Floor
Toronto, Ontario
M4S 3E2
Canada

Phone +1 416 489 7100
Email mail@hsf.on.ca
ROR logo "ROR" https://ror.org/00qbpyp73

Funders

Funder type

Charity

The Heart and Stroke Foundation of Ontario (Canada)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article Protocol 22/12/2003 Yes No